Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGHG.L Regulatory News (GHG)

  • There is currently no data for GHG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Stabilisation Notice

9 Nov 2015 07:16

RNS Number : 9705E
Citigroup Global Markets Limited
09 November 2015
 



Pre-stabilisation notice

 

9 November 2015

 

Not for release, publication or distribution, in whole or in part, directly or indirectly, in or into the United States of America, Australia, Canada, Japan, New Zealand or South Africa or any jurisdiction in which such distribution would be unlawful.

 

Georgia Healthcare Group PLC

 

Stabilisation Notice

 

Citigroup Global Markets Limited (Contact: Syndicate Desk +44 20 7986 9000) hereby gives notice that the Stabilising Manager named below and its affiliates may stabilise the offer of the following securities in accordance with Commission Regulation (EC) No. 2273/2003 implementing the Market Abuse Directive (2003/6/EC).

 

The securities:

Issuer:

Georgia Healthcare Group PLC

Securities:

Ordinary Shares with a nominal value of £0.10 each

ISIN:

GB00BYSS4K11

Offering size:

38,681,820 Ordinary Shares excluding the over-allotment option

Description:

Initial Public Offering of Ordinary Shares

Offer price:

170 pence per Ordinary Share

Associated securities:

There are no associated instruments that are subject to stabilisation

Stabilisation:

Stabilising Manager:

Citigroup Global Markets Limited, Citigroup Centre, Canada Square, Canary Wharf, London E14 5LB, United Kingdom

 

Stabilisation period expected to start on:

9 November 2015 (approximately 08.00a.m.(London time))

Stabilisation period expected to end no later than:

8 December 2015 (close of business)

Existence, maximum size and conditions of use of over-allotment facility.

The Stabilising Manager may over-allot the securities to the extent permitted in accordance with applicable law, up to the maximum size of 3,868,180 Ordinary Shares.

Over-allotment Option:

Terms:

JSC BGEO Investments has granted Citigroup Global Markets Limited, in its capacity as Stabilising Manager and for the account of the underwriters, the option to acquire up to an additional 3,868,180 Ordinary Shares at the offer price.

Duration:

This option may be exercised in full or in part at any time during the stabilisation period.

 

In connection with the offer of the above securities, the Stabilising Manager may over-allot the securities or effect transactions with a view to supporting the market price of the securities at a level higher than that which might otherwise prevail. However, there is no assurance that the Stabilising Manager will take any stabilisation action and any stabilisation action, if begun, may be ended at any time. Any stabilisation action or over-allotment shall be conducted in accordance with all applicable laws and rules.

 

This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction.

 

This announcement and the offer of the securities to which it relates are only addressed to and directed at persons outside the United Kingdom and persons in the United Kingdom who have professional experience in matters related to investments or who are high net worth persons as referred to in article 12(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 and must not be acted on or relied on by other persons in the United Kingdom.

 

In addition, if and to the extent that this announcement is communicated in, or the offer of the securities to which it relates is made in, any EEA Member State that has implemented Directive 2003/71/EC, as amended (together with any applicable implementing measures in any Member State, the "Prospectus Directive") before the publication of a prospectus in relation to the securities which has been approved by the competent authority in that Member State in accordance with the Prospectus Directive (or which has been approved by a competent authority in another Member State and notified to the competent authority in that Member State in accordance with the Prospectus Directive), this announcement and the offer are only addressed to and directed at persons in that Member State who are qualified investors within the meaning of the Prospectus Directive (or who are other persons to whom the offer may lawfully be addressed) and must not be acted on or relied on by other persons in that Member State.

 

This announcement is not an offer of securities for sale into the United States. The securities have not been, and will not be, registered under the United States Securities Act of 1933 and may not be offered or sold in the United States absent registration or an exemption from registration. There will be no public offer of securities in the United States.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STABLBRTMBBMMIA
Date   Source Headline
24th Oct 20167:00 amRNSGHG launches a new ambulatory cluster
10th Oct 20167:00 amRNSGHG Investor Day Notice
12th Sep 20167:00 amRNSGHG signs loan agreement with IFC
24th Aug 20167:00 amRNSGHG launches a new ambulatory cluster in Tbilisi
15th Aug 20167:00 amRNSHalf-year Report
11th Aug 20167:00 amRNSGHG signs loan agreement with Proparco
11th Aug 20167:00 amRNSNotice of Results
9th Aug 20167:00 amRNSGHG launches outpatient and diagnostic centres
8th Aug 20167:00 amRNSSave the date GHG investor day 23 November
1st Aug 20167:00 amRNSGHG launches a new ambulatory cluster in Tbilisi
27th Jul 20164:40 pmRNSSecond Price Monitoring Extn
27th Jul 20164:35 pmRNSPrice Monitoring Extension
20th Jul 20167:00 amRNSGHG announces appointment of corporate brokers
28th Jun 20163:10 pmRNSDirector/PDMR Shareholding
13th Jun 20167:00 amRNSGHG announces appointment of CEO of Imedi L
26th May 20164:26 pmRNSResult of AGM
17th May 20167:00 amRNS1st Quarter Results
16th May 20167:00 amRNSGHG launches a new ambulatory cluster in Tbilisi
13th May 20167:03 amRNSNotice of the first quarter 2016 results
5th May 20167:03 amRNSHealthcare subsidiary completes acquisition of GPC
5th May 20167:00 amRNSGHG announces completion of the acquisition of GPC
25th Apr 20162:16 pmRNSNotice of AGM
14th Apr 20165:58 pmRNSHolding(s) in Company
14th Apr 20167:51 amRNSLaunch of In Vitro Fertilisation service
13th Apr 20165:36 pmRNSHolding(s) in Company
8th Apr 20165:35 pmRNSAnnual Financial Report
7th Apr 20165:37 pmRNSDirector/PDMR Shareholding
16th Mar 20167:04 amRNSGHG announces appointment of Deputy CEO
16th Mar 20167:00 amRNSAcquisition
23rd Feb 20167:00 amRNSGHG buys out minority at major referral hospital
15th Feb 20167:00 amRNSFinal Results
11th Feb 20163:20 pmRNSNotice of Q4 and Full Year Results
13th Jan 20165:29 pmRNSGHG's Reduction of Capital becomes effective
13th Jan 20167:00 amRNSGHG appoint Chief Clinical Officer
30th Dec 20157:00 amRNSGHG launches two ambulatory clusters
23rd Nov 201510:03 amRNSGHG Q3 results announced as part of BGEO's results
23rd Nov 20157:01 amRNSGeorgia Healthcare Group - Stabilisation Notice
12th Nov 20152:38 pmRNSGHG announces Admission to Trading
9th Nov 20155:36 pmRNSPublication of Prospectus
9th Nov 20157:46 amRNSGHG Prospectus Publication correction
9th Nov 20157:16 amRNSStabilisation Notice
9th Nov 20157:00 amRNSPublication of Prospectus
9th Nov 20157:00 amRNSGHG announces the Offering Price for its IPO

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.